Search Results

Career opportunities:  New openings for a postdoctoral research position in GPCR biochemistry and biophysics Avoid missed opportunities:  Discover how to identify and target cryptic intracellular allosteric sites GPCR Podcast : The Future of GPCR Drug Discovery with Molecular Modeling The field of GPCR research is Learn how his research aims to develop models that can distinguish between active and inactive ligands

A conserved intracellular allosteric binding site (IABS) has recently been identified at several G protein-coupled showing that our CCR9-PROTAC is able to reduce CCR9 levels, thereby offering an unprecedented approach to modulate

Expression Ligand bias at the muscarinic acetylcholine receptor family: opportunities and challenges Modulating Structural and Molecular Insights into GPCR Function Vibrational Energy Landscapes and Energy Flow in GPCRs Allosterism Industry News Confo Therapeutics Announces EUR 60M Series B Financing to Advance a Pipeline of Novel GPCR-Modulating July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology GPCR Jobs NEW Postdoctoral Position NEW Postdoctoral research position Senior or Lead Researcher Senior Scientist, Cryo-Electron Microscopy

GPCR Symposium on ''GPCRs as Therapeutic Modalities' Share your project with a 1-minute abstract video involved in the innate immune response of Tribolium castaneum GPCR Activation and Signaling Biased allosteric Discovery On Target September 27 - 28, 2023 | Training Seminar "The Renaissance in GPCRs as Drug Targets: Allosteric

We report that arrestin-3 modulates Fgr activity with a hallmark bell-shaped concentration-dependence interaction, we determined the crystal structure of the Fgr SH3 domain at 1.9 Å resolution and developed a model This model suggests that Fgr interacts with arrestin-3 at multiple sites and is consistent with the locations

GPCR Binders, Drugs, and more Allosteric modulator potentiates β2AR agonist-promoted bronchoprotection in asthma models.

September 2022 "Metabotropic γ-aminobutyric acid receptor (GABABR), a class C G protein-coupled receptor (GPCR) heterodimer, plays a crucial role in the central nervous system. Cryo-electron microscopy studies revealed a drastic conformational change upon activation and a unique G protein (GP) binding mode. However, little is known about the mechanism for GP coupling and activation for class C GPCRs. Here, we use molecular metadynamics computations to predict the mechanism by which the inactive GP induces conformational changes in the GABABR transmembrane domain (TMD) to form an intermediate pre-activated state. We find that the inactive GP first interacts with TM3, which further leads to the TMD rearrangement and deeper insertion of the α5 helix that causes the Gα subunit to open, releasing GDP, and forming the experimentally observed activated structure. This mechanism provides fresh insights into the mechanistic details of class C GPCRs activation expected to be useful for designing selective agonists and antagonists." Read more at the source #DrGPCR #GPCR #IndustryNews

5th to 11th, 2024 GPCR Activation and Signaling Constitutive activation mechanism of a class C GPCR Allosteric modulation and G-protein selectivity of the Ca2+-sensing receptor GPCRs in Cardiology, Endocrinology Research GPCR-BERT: Interpreting Sequential Design of G Protein-Coupled Receptors Using Protein Language Models Imaging Center NEW Scientific Assistant Postdoctoral Fellowship- Mechanistic Biology Research Scientist Post-Doc position Lead Researcher Join Dr.

Statin-induced increase in actin polymerization modulates GPCR dynamics and compartmentalization. The G protein-coupled receptor neuropeptide receptor-15 modulates larval development via the transforming Stabilization of pre-existing neurotensin receptor conformational states by β-arrestin-1 and the biased allosteric modulator ML314. Scientist II DOE (Native Mass Spectrometry) Senior Vice President of Global Medical Affairs Postdoctoral Position

Breakthroughs this week: McGPCR multimodal model; Endocrine Metabolic GPCRs 2026; Pfizer–Metsera acquisition why misclassification propagates error across affinity estimates, mechanism claims, and downstream modeling Watch the trailer 👇 What you’ll gain Validate the model behind the data.   four canonical criteria to distinguish genuine orthosteric antagonism from apparent shifts that mask allosterism

of polycystic ovarian syndrome by modulating GPCR41/43 and PROKR1 GPCRs in Neuroscience Diverse signaling prologue Industry News Exscientia Business Update for Third Quarter 2023 Addex CEO Tim Dyer to Discuss Allosteric Modulators in Neurological Disorders at Jefferies Healthcare Conference in London Sosei Heptares and NEW July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology 2026 GPCR Jobs NEW Post-Doc Postdoctoral Fellow Research Scientist/Postdoctoral Associate in Computational Chemistry/Biophysics Post-Doctoral

3 activation Michael Trogdon, J Silvio Gutkind, Edward C Stites, et al., for their study on Systems modeling its Aldehyde from a Marine Cyanobacterium Fluorophore-Labeled Pyrrolones Targeting the Intracellular Allosteric beige adipocyte formation: Implications for obesity and metabolic health GPCRs in Neuroscience Chronic modulation treatment based on drug repurposing demonstrates mutation-agnostic efficacy in pre-clinical retinopathy models Cryo-Electron Microscopy Postdoctoral Research Associate Senior Scientist - Discovery Biotherapeutics Post-Doctoral

Brake for Airway Smooth Muscle Cell Movement Hepatic extracellular ATP/adenosine dynamics in zebrafish models Chemoattractant receptor signaling in humoral immunity Industry News Neurosterix launches with $63M to Advance Allosteric Modulator Therapeutics for Neurological Disorders Aelis Farma Reports Its 2023 Annual Financial Resultsand

and has synergistic effects with anticancer agents.[1–3] These insights highlight the potential in modulating New scaffolds modulating the CBRs in both the orthosteric and allosteric sites have been developed, supported by resolved crystal structures of both CBRs.[4–8] A key challenge in CBR modulator development is separating Translational Potential of Allosteric Modulators Targeting the Cannabinoid CB1 Receptor. Identification of the First Synthetic Allosteric Modulator of the CB2 Receptors and Evidence of Its Efficacy

for their investigation on Modulation of contextual fear acquisition and extinction by acute and chronic internalization of cognate GPCRs and disrupt downstream intracellular signaling Therapeutic potential of allosteric modulators for the treatment of gastrointestinal motility disorders GPCRs in Cardiology, Endocrinology Neuroscience Neuron specific quantitation of Gαolf expression and signaling in murine brain tissue Modulation cortex Unveiling the therapeutic prospects of EGFR inhibition in rotenone-mediated parkinsonism in rats: Modulation

In particular, CBD is able to modulate different receptors in the endocannabinoid system, some of which While in the former, CBD has been demonstrated to function as an antagonist, the way by which CBD modulates suggested to directly trigger receptor’s activation, stabilize CB1 inactive conformations or function as an allosteric modulator. These results are in agreement with the proposed modulatory function of each ligand, showing that the

Orthosteric and allosteric antagonists of C5aR1 are a novel strategy for anti-inflammatory therapies.

We then highlight the evidence supporting the use of various drugs including orthosteric and allosteric

SUCNR1 signaling in adipocytes controls energy metabolism by modulating circadian clock and leptin expression Sodium is a negative allosteric regulator of the ghrelin receptor. October 25 - 27, 2023) GPCR Jobs Convergent Research - Senior Scientist, Cell-Based Assay Development Post in protein production Vice President, Oncology Clinical Research PostDoctoral Associate PostDoctoral Position Team Lead protein production and profiling Pharmacologist Postdoctoral positions at UC San Diego Medical

GPCR Symposium on GPCRs as Therapeutic Modalities is on September 22nd. GPCR Activation and Signaling Endosome positioning coordinates spatially selective GPCR signaling. Structural and Molecular Insights into GPCR Function Ternary model structural complex of C5a, C5aR2, Target (September 25 - 28, 2023) ○ NEW Training Seminar "The Renaissance in GPCRs as Drug Targets: Allosteric

There are only two drugs in the market targeting chemokine receptors: maraviroc, an allosteric and reversible receptors can homo- and hetero-oligomerize, impacting receptor/ligand-binding and signaling patterns, by modulating These larger interfaces represent the typical protein-protein interactions which are difficult to modulate Overall, the future potential lies in using different therapeutic modalities to modulate the stromal

The structure demonstrates a unique ligand-binding mode, involving an allosteric sub-pocket, which clarifies

Career opportunities: Senior Scientist roles; Postdoctoral GPCR positions. Must-read publications: D2 receptor constitutively active mutants; β2AR allosteric SERS assay; CXCR4 Why consider contributing: Position your work within a focused, visible GPCR signaling collection.

form biologically active homodimers or heterodimers which drive specific signaling pathways that can modulate highlight the importance of GPCR dimers in drug discovery referring to important conformational changes, allosteric al. recently provided key insights into GPCR oligomerization and biased signalling, using PAFR as a model Different models of dimer formation have been described for different receptors such as the ‘rolling dimer’ interface model in which multiple dimer conformations co-exist and interconvert (P.M.

failure drug following reverse merger with Avrobio Addex Pharma unveils new mGlu7 receptor negative allosteric modulators Trevena Announces Preclinical TRV045 Data Providing Insight Into Novel Mechanism of Analgesic in Epilepsy Models Biophysicists decipher functionality of adrenaline-binding receptor Tectonic plates Basic and Clinical Pharmacology 2026 GPCR Jobs HIGHLIGHT Principal Scientist, In vitro pharmacology NEW Post-Doctoral Pharmacology Postdoctoral Scientist Senior Research Associate/Associate Scientist, Protein Science Post-Doctoral

The midpoint and maximum—core parameters for downstream modeling—are only meaningful when the assay fully Unexpected outcomes typically trace back to a single issue: transferring assumptions from idealized models This frequently masquerades as: Two binding sites Multiple receptor subtypes Allosteric modulation But

Now you can submit your job opening and offer a position in an exclusive GPCR community around the globe Reviews, GPCRs, and more Internal and external modulation factors of the orexin system (REVIEW). Industry News A Current View of Allosteric GPCR Drug Discovery from the 2nd Annual GPCRs-Targeted Drug NEW Scientist—Immuno-Oncology Convergent Research - Senior Scientist, Cell-Based Assay Development Post in protein production Vice President, Oncology Clinical Research PostDoctoral Associate PostDoctoral Position

effects on mouse metabolism Mechanistic insights into sodium ion-mediated ligand binding affinity and modulation analysis Unveiling the therapeutic prospects of EGFR inhibition in rotenone-mediated parkinsonism in rats: Modulation Excellence Awards Domain Therapeutics to Present Latest Data on DT-9045, a First-in-class Negative Allosteric Modulator of PAR2 for Immuno-oncology Crinetics Pharmaceuticals gets grant for patent granted for somatostatin modulators for treating hormone-related conditions Sosei Heptares Confirms Re-election of its Board

An allosteric modulator of the adenosine A1 receptor potentiates the antilipolytic effect in rat adipose Molecule Created Through Generative AI Platform to Enter Clinical Stage X4 Pharmaceuticals Announces Positive

October 2022 ADGRL3 genomic variation implicated in neurogenesis and ADHD links functional effects to the incretin polypeptide GIP "Attention deficit/hyperactivity disorder (ADHD) is the most common childhood neurodevelopmental disorder. Single nucleotide polymorphisms (SNPs) in the Adhesion G Protein-Coupled Receptor L3 (ADGRL3) gene are associated with increased susceptibility to developing ADHD worldwide. However, the effect of ADGRL3 non-synonymous SNPs (nsSNPs) on the ADGRL3 protein function is vastly unknown. Using several bioinformatics tools to evaluate the impact of mutations, we found that nsSNPs rs35106420, rs61747658, and rs734644, previously reported to be associated and in linkage with ADHD in disparate populations from the world over, are predicted as pathogenic variants. Docking analysis of rs35106420, harbored in the ADGLR3-hormone receptor domain (HRM, a common extracellular domain of the secretin-like GPCRs family), showed that HRM interacts with the Glucose-dependent insulinotropic polypeptide (GIP), part of the incretin hormones family. GIP has been linked to the pathogenesis of diabetes mellitus, and our analyses suggest a potential link to ADHD. Overall, the comprehensive application of bioinformatics tools showed that functional mutations in the ADGLR3 gene disrupt the standard and wild ADGRL3 structure, most likely affecting its metabolic regulation. Further in vitro experiments are granted to evaluate these in silico predictions of the ADGRL3-GIP interaction and dissect the complexity underlying the development of ADHD." Read more at the source #DrGPCR #GPCR #IndustryNews